Postural Stability and Ankle Mobility in Haglund Syndrome

NCT ID: NCT05905952

Last Updated: 2023-06-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-12

Study Completion Date

2023-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to find out the impact of Haglund syndrome on ankle plantarflexion and dorsiflexion ROM, dynamic postural stability and fall risk.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be delimited to:

* Total sample size is fifty participants, twenty five patient of symptomatic Haglund syndrome of both gender and twenty five healthy volunteers of matched age, sex and body mass index without any musculoskeletal complaints of the lower limbs.
* Biodex balance system will be used to determine postural stability.
* Ankle plantarflexion and dorsiflexion range of motion will be measured using an Electrogoniometer.
* Age of the patients 25-56
* BMI of (18.5 to 24.9)

Participants:

Fifty volunteers from both genders will participate in the study. They will be assigned from outpatient clinic of Faculty of Physical Therapy, Deraya University. They will be interviewed and divided to twenty five patient of Haglund syndrome as (patient group) after being diagnosed and referred by orthopedic surgeon and twenty five Healthy volunteers as (control group) based on the following inclusion and exclusion criteria:

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Haglund Deformity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patient group

to twenty five patient of Haglund syndrome as (patient group) after being diagnosed and referred by orthopedic surgeon and twenty

balance and ROM assessment

Intervention Type DIAGNOSTIC_TEST

assessment of postural stability and ankle range of motion

control group

twenty five Healthy volunteers as (control group) based on the following inclusion and exclusion criteria

balance and ROM assessment

Intervention Type DIAGNOSTIC_TEST

assessment of postural stability and ankle range of motion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

balance and ROM assessment

assessment of postural stability and ankle range of motion

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* For patient group:

* Patient referred from orthopedic surgeon with diagnoses as Haglund syndrome according to the following signs and symptoms
* Calcaneal prominence diagnosed on lateral weight bearing radiograph with bony prominence superior to parallel pitch lines or posterior calcaneal angle greater than 75 degrees
* Pain medially at insertion of tendo-achilles
* Palpation of hard, bony prominence
* Pain upon rising out of bed
* Both unilateral and bilateral cases, and in consideration of dealing with bilateral cases the tested limb will be the most painful limb.
* Age of 25-56 years
* Both males and females.
* BMI of (18.5 to 24.9)

For control group:

Healthy volunteers of matched age, sex and body mass index without any musculoskeletal complaints of the lower limbs and will be included in the control group in this study .

Exclusion Criteria

* Musculoskeletal disorders except Haglund syndrome
* cognitive disorder, visual impairment that affected their daily living and any further medical condition that would prohibit them from participating safely in the chosen balance measures
* sensory loss at foot or ankle and with a systemic inflammatory disease, such as diabetes mellitus, peripheral neuropathy, rheumatoid arthritis and ankylosing spondylitis, who had undergone corticosteroid injections or physical therapy in the last three months
* Patients with vestibular or neurological disorders
* Any other cause of posterior heel pain.
Minimum Eligible Age

25 Years

Maximum Eligible Age

56 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nassif Magdy Mousa

principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

enas F youssif, prof

Role: PRINCIPAL_INVESTIGATOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Deraya University

Minya, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

nassif M mousa, Bachelor

Role: CONTACT

01273152233 ext. el minia

enas F youssif, prof

Role: CONTACT

01127867507 ext. cairo

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

nassif M mousa, bachelor

Role: primary

01273152233

mohamed A abdelmegeed, PHD

Role: backup

01223631604

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/ 012/004497

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.